A news brief in the June 17, 2003, issue of BioWorld Today should have said The Genetics Co. AG, of Schlieren, Switzerland, acquired assets, tools and assays to monitor amyloid-beta peptide levels from Abeta GmbH, of Heidelberg, Germany.

Also, a story in the June 18, 2003 issue of BioWorld Today should have said BioMarin Pharmaceutical Inc.'s stock (NASDAQ:BMRN) lost $1.71 Tuesday to close at $10.81.

Editor's note: The changes were made on BioWorld Online.